Gujarat Themis Biosyn Ltd.
Snapshot View

510.25 +2.75 ▲0.5%

18 August 2022, 04:01:00 PM
Volume: 15,428

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gtbl.in
Market Cap 735.52 Cr.
Enterprise Value(EV) 723.17 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 33.36 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 15.17 Trailing Twelve Months Ending 2022-06
Industry PE 32.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 83.35 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.07 Calculated using Price: 506.25
Dividend Yield 2.17 Period Ending 2022-03
No. of Shares Subscribed 1.45 Cr. 14,528,702 Shares
FaceValue 5
Company Profile
Gujarat Themis Biosyn Ltd, established in 1981, is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $ 40 million. It has EDMFs, available and WHO approved plants.The company has world-wide exports to satisfied customers, having customised facility for all products.The company’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.54%
1 Week
+0.13%
1 Month
+19.09%
3 Month
+19.09%
6 Month
+42.87%
1 Year
+17.84%
2 Year
+175.36%
5 Year
+1110.56%
10 Year
+5569.44%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 302.71 72.63 38.06 41.85 77.99 53.82 50.35
Return on Capital Employed (%) 209.07 113.74 80.38 54.67 42.22 44.88 85.96 67.89 67.91
Return on Assets (%) 26.54 29.88 31.50 24.25 18.45 24.07 45.62 35.65 37.08

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds -10 -5 -1 4 8 12 19 42 70 103
Non Curr. Liab. 7 6 6 2 1 0 1 5 2 2
Curr. Liab. 21 15 10 9 12 8 13 24 26 32
Minority Int.
Equity & Liab. 18 16 15 15 21 20 33 71 98 137
Non Curr. Assets 14 13 11 11 13 13 25 35 25 44
Curr. Assets 4 3 3 3 8 8 8 36 73 93
Misc. Exp. not W/O
Total Assets 18 16 15 15 21 20 33 71 98 137

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 30 31 33 36 39 41 85 91 115 127
Other Income 0 0 0 0 0 2 2 3 4 4
Total Income 30 32 33 36 39 43 87 94 119 132
Total Expenditure -24 -25 -27 -30 -33 -34 -53 -50 -57 -63
PBIDT 7 6 6 6 6 10 34 44 62 68
Interest -1 0 0 0 0 0 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -2 -2 -2
Taxation -1 -1 -2 -8 -11 -15 -17
Exceptional Items
PAT 5 5 5 4 4 6 24 30 44 48
Adjusted EPS 3 3 3 3 3 4 16 21 30 33

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 4 3 4 3 6 1 1 11 40
Cash Fr. Inv. -3 0 0 -1 -3 -1 -6 -3 -2 -30
Cash Fr. Finan. 2 -3 -3 -3 0 -4 5 2 -5 -14
Net Change 0 1 -1 0 0 1 0 0 3 -4
Cash & Cash Eqvt 0 1 0 0 0 1 1 1 4 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
Public 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 17 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation 2015 we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received below mentioned intimation / request(s) for Loss of Share Certificate(s) / issuance of duplicate share certificate(s) from the following shareholder(s):Sr. No. Name Folio No. Cert. No. Number of Shares Dist. No.From Dist. No.To1. K SUNDARARAJAN K000100 5477 50 1732951 1733000 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the Shareholder(s).
Wed, 17 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of Regulation 47 of the SEBI (LODR) Regulations 2015 the Company has published the notice in Western Times (English) edition dated August 17 2022 & in Western Times (Gujarati) edition dated August 17 2022 which includes the following information; a) Intimation of 41st Annual General Meeting (AGM) of our Company to be held through video conferencing / other audio-visual means and confirmation of dispatch of Annual Report for the Financial Year 2021-22 along with Notice of the AGM.b) Particulars of the facility of e-voting provided to Members of the Company to enable them to cast their votes on the resolutions proposed to be passed at the AGM.Further in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in above mentioned newspapers.
Tue, 16 Aug 2022
Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of the Annual Report of the Company for the financial year ended 31st March 2022 along with the Notice convening the 41st Annual General Meeting (AGM) to be held on Wednesday September 7 2022 at 12:00 Noon through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

Technical Scans View Details >>

Thu, 18 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,779.08 916.00 -0.5%
Divi's Laboratories Ltd. 99,402.06 3,744.40 -0.1%
Cipla Ltd. 83,298.12 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. 70,326.13 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. 61,347.88 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. 52,831.33 1,564.95 +0.5%
Piramal Enterprises Ltd. 46,812.69 1,961.10 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.51 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 32.01 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 33.50 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.51 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.51 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.12 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 24.90 1,961.10 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 8.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 3.88 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.47 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.33 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 1.31 1,961.10 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,961.10 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,961.10 -0.7%

FAQ's On Gujarat Themis Biosyn Ltd.

Can I Buy Guj. Themis Biosyn Shares now?

What is the Share Price of Guj. Themis Biosyn?

What is the Relative Strength Index (RSI) Value of Guj. Themis Biosyn?

What is the Market Capital (MCAP) of Guj. Themis Biosyn?

What are the key metrics to analyse Guj. Themis Biosyn?

What is the Price Performance of Guj. Themis Biosyn?